BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li B, Chen X, Qiu W, Zhao R, Duan J, Zhang S, Pan Z, Zhao S, Guo Q, Qi Y, Wang W, Deng L, Ni S, Sang Y, Xue H, Liu H, Li G. Synchronous Disintegration of Ferroptosis Defense Axis via Engineered Exosome-Conjugated Magnetic Nanoparticles for Glioblastoma Therapy. Adv Sci (Weinh) 2022;9:e2105451. [PMID: 35508804 DOI: 10.1002/advs.202105451] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu J. Research advances in the understanding of how exosomes regulate ferroptosis in cancer. Clin Transl Oncol 2023. [PMID: 36705798 DOI: 10.1007/s12094-023-03089-6] [Reference Citation Analysis]
2 Chen S, Yang J, Liang Z, Li Z, Xiong W, Fan Q, Shen Z, Liu J, Xu Y. Synergistic Functional Nanomedicine Enhances Ferroptosis Therapy for Breast Tumors by a Blocking Defensive Redox System. ACS Appl Mater Interfaces 2023;15:2705-13. [PMID: 36622364 DOI: 10.1021/acsami.2c19585] [Reference Citation Analysis]
3 Lu ZG, Shen J, Yang J, Wang JW, Zhao RC, Zhang TL, Guo J, Zhang X. Nucleic acid drug vectors for diagnosis and treatment of brain diseases. Signal Transduct Target Ther 2023;8:39. [PMID: 36650130 DOI: 10.1038/s41392-022-01298-z] [Reference Citation Analysis]
4 Zhou Z, You B, Ji C, Zhang L, Wu F, Qian H. Implications of Crosstalk between Exosome-Mediated Ferroptosis and Diseases for Pathogenesis and Treatment. Cells 2023;12. [PMID: 36672245 DOI: 10.3390/cells12020311] [Reference Citation Analysis]
5 Cui J, Wang X, Li J, Zhu A, Du Y, Zeng W, Guo Y, Di L, Wang R. Immune Exosomes Loading Self-Assembled Nanomicelles Traverse the Blood-Brain Barrier for Chemo-immunotherapy against Glioblastoma. ACS Nano 2023. [PMID: 36626296 DOI: 10.1021/acsnano.2c10219] [Reference Citation Analysis]
6 Allami P, Heidari A, Rezaei N. The role of cell membrane-coated nanoparticles as a novel treatment approach in glioblastoma. Front Mol Biosci 2022;9:1083645. [PMID: 36660431 DOI: 10.3389/fmolb.2022.1083645] [Reference Citation Analysis]
7 Wang L, Fu H, Song L, Wu Z, Yu J, Guo Q, Chen C, Yang X, Zhang J, Wang Q, Duan Y, Yang Y. Overcoming AZD9291 Resistance and Metastasis of NSCLC via Ferroptosis and Multitarget Interference by Nanocatalytic Sensitizer Plus AHP-DRI-12. Small 2023;19:e2204133. [PMID: 36420659 DOI: 10.1002/smll.202204133] [Reference Citation Analysis]
8 Chen X, Wang C, Hao M, Zhao H, Xia H, Yu L, Li D, Qiu J, Li H, Han L, Sang Y. Mesoporous Silica Promotes Osteogenesis of Human Adipose-Derived Stem Cells Identified by a High-Throughput Microfluidic Chip Assay. Pharmaceutics 2022;14. [PMID: 36559224 DOI: 10.3390/pharmaceutics14122730] [Reference Citation Analysis]
9 Zhang X, Ge H, Ma Y, Song L, Ma Y, Tian G, Wang L, Meng Q, Sun X. Engineered Anti-cancer Nanomedicine for Synergistic Ferroptosis-Immunotherapy. Chemical Engineering Journal 2022. [DOI: 10.1016/j.cej.2022.140688] [Reference Citation Analysis]
10 Luo Y, Tian G, Fang X, Bai S, Yuan G, Pan Y. Ferroptosis and Its Potential Role in Glioma: From Molecular Mechanisms to Therapeutic Opportunities. Antioxidants 2022;11:2123. [DOI: 10.3390/antiox11112123] [Reference Citation Analysis]